Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 33

Sort by

Sort Order Select

Journal Articles

Ethical Issues and Barriers for Multi-National Paediatric Clinical Trials: The Challenging Experience of the DEEP Project

Viviana Giannuzzi, PhD, Mariagrazia Felisi, PhD, Hugo Devlieger, Aurelio Maggio, MD, George Papanikolaou, MD PhD, Giorgio Reggiardo, Bianca Tempesta, PhD, Fernando Tricta, MD, Donato Bonifazi

Blood (2019) 134 (Supplement_1): 4820.

https://doi.org/10.1182/blood-2019-124689

Published: 2019

Journal Articles

Mass Spectrometry-Based Immunopeptidome Analysis of Acute Myeloid Leukemia Cells Under Decitabine Treatment Delineates Induced Presentation of Cancer/Testis Antigens on HLA Class I Molecules

Jens Bauer, Nora Zieger, Annika Nelde, Leon Bichmann, Helmut R. Salih, MD, Lothar Kanz, Hans-Georg Rammensee, Stefan Stevanovic, Juliane S. Walz

Blood (2018) 132 (Supplement 1): 5223.

https://doi.org/10.1182/blood-2018-99-113357

Published: 2018

Journal Articles

Somatic PRAME Deletions Are Associated with Decreased Immunogenicity, Apoptosis Resistance and Poor Outcomes in Diffuse Large B-Cell Lymphoma

Katsuyoshi Takata, MD PhD, Daisuke Ennishi, MDPhD, Ali Bashashati, Saeed Saberi, Elena Viganò, PhD, Shannon Healy, PhD, Julie S Nielsen, Gianluca D' Antonio, Brad H Nelson, Sohrab P Shah, Joseph M Connors, Randy D. Gascoyne, MD, David W. Scott, PhDMD,FRACP,FRCPA, Christian Steidl, MD

Blood (2018) 132 (Supplement 1): 667.

https://doi.org/10.1182/blood-2018-99-113516

Published: 2018

Journal Articles

TFDP3 and DDX53 are Highly Re-Expressed after One Cycle of Azacitidine in Myelodysplastic Syndrome Patients Achieving Complete Response: A Cancer Testis Antigen RNA-Seq Screening

Ana M Hurtado López, Tzu Hua Chen-Liang, Joaquín Panadero, Eduardo José Salido, MD, Victor Beltrán, Begoña Muiña, Noelia Navarro-Villamor, Inés Calabria, Ana Isabel Antón, Francisco José Ortuño, Vicente Vicente, MD PhD, Andres Jerez

Blood (2018) 132 (Supplement 1): 4340.

https://doi.org/10.1182/blood-2018-99-117851

Published: 2018

Journal Articles

Molecular profiling reveals immunogenic cues in anaplastic large cell lymphomas with DUSP22 rearrangements

Blood (2018) 132 (13): 1386–1398.

https://doi.org/10.1182/blood-2018-03-838524

Published: 2018

Includes: Supplemental data

Journal Articles

Global and Targeted RNA-Sequencing Assessment of Cancer Testis Antigen Re-Expression Following Azacitidine in Myelodysplastic Syndromes

Ana M Hurtado, Tzu Hua Chen-Liang, Joaquín Panadero, Eduardo José Salido, MD, Victor Beltrán, Begoña Muiña, Noelia Navarro-Villamor, Inés Calabria, Ana Isabel Antón, Andres Jerez

Blood (2017) 130 (Supplement 1): 1695.

https://doi.org/10.1182/blood.V130.Suppl_1.1695.1695

Published: 2017

Journal Articles

Transcriptomic and Network Signatures of Cryptic Fusion CBFA2T3-GLIS2 in Pediatric AML Reveals Clinical Considerations and Implications

Jenny L. Smith, MSc, MD, Rhonda E. Ries, MA, Heather Louise Schuback, MD, Lisa E. Brodersen, PhD, Michael R. Loken, PhD, Hamid Bolouri, PhD, Soheil Meshinchi, MD PhD

Blood (2017) 130 (Supplement 1): 1193.

https://doi.org/10.1182/blood.V130.Suppl_1.1193.1193

Published: 2017

Journal Articles

Evaluation of Cancer Testis Antigens (CTAs) As Immuno-Therapeutic Targets in Pediatric AML

Rhonda E. Ries, MA, Jenny L. Smith, MSc, MD, Tim Triche, PhD, Jason E. Farrar, MD, Todd A Alonzo, PhD, Yussanne Ma, PhD, Lisa Wei, BS, Jaime Guidry Auvil, PhD, Daniela S. Gerhard, PhD, Marco A Marra, PhD, Alan S Gamis, MD MPH, Anders Kolb, MD, Hamid Bolouri, PhD, Soheil Meshinchi, MD PhD

Blood (2017) 130 (Supplement 1): 107.

https://doi.org/10.1182/blood.V130.Suppl_1.107.107

Published: 2017

Journal Articles

Induction of Cancer Testis Antigen Expression in Circulating Acute Myeloid Leukemia Blasts Following Hypomethylating Agent Monotherapy

Pragya Srivastava, PhD, Benjamin E. Paluch, Junko Matsuzaki, PhD, Smitha R. James, Golda Collmat-Lai, Nadja Blagitko-Dorfs, Laurie Ann Ford, Rafeh Naqash, MD, Michael Luebbert, MD, Adam R. Karpf, PhD, Michael J. Nemeth, PhD, Elizabeth A. Griffiths, MD

Blood (2015) 126 (23): 2537.

https://doi.org/10.1182/blood.V126.23.2537.2537

Published: 2015

Journal Articles

Incidence of Pulmonary Embolism with Concomitant Deep Vein Thrombosis at an Urban Community Teaching Hospital

Uri Goldberg, MD, Wazhma Nasiri, Mohamed Alibakhiet, Henry Jean, MD, Rajat Mukherji, MD, Madhumati Kalavar, MD

Blood (2015) 126 (23): 4716.

https://doi.org/10.1182/blood.V126.23.4716.4716

Published: 2015

Journal Articles

An Interphase Chromosome Profiling Assay to Determine the Need for CD 138 Enrichment in the Genetic Workup of Multiple Myeloma

Ramesh Babu, PhD, MBA, Prasad Koduru, PhD

Blood (2015) 126 (23): 4211.

https://doi.org/10.1182/blood.V126.23.4211.4211

Published: 2015

Journal Articles

Novel Evidence That Neuroblastoma and Rhabdomyosarcoma, Two Types of Small Round Blue Cell Tumors, Frequently Infiltrate Bone Marrow and Express Functional Erythropoietin Receptor (EpoR)—therapeutic Implications

Agata Poniewierska-Baran, MS, Gabriela Schneider, PhD, Janina Ratajczak, MD PhD, Magdalena Kucia, PhD, Mariusz Z Ratajczak, MD PhD

Blood (2014) 124 (21): 4019.

https://doi.org/10.1182/blood.V124.21.4019.4019

Published: 2014

Journal Articles

The Cancer/Testis Antigens of SSX4, MAGE-A3, and CTAG2 Are Attractive Targets for Cancer Immunotherapy in Korean Patients with Multiple Myeloma

Nu-Ri Choi, Sung-Hoon Jung, Hyun-Ju Lee, Manh-Cuong Vo, My-Dung Hoang, Hyeoung-Joon Kim, MD PhD, Je-Jung Lee, MD PhD

Blood (2014) 124 (21): 5757.

https://doi.org/10.1182/blood.V124.21.5757.5757

Published: 2014

Journal Articles

Synergistic Reactivation Of Cancer/Testis Antigens By Combination Treatment With Decitabine and Histone Deacetylase Inhibitors (Valproate, Panobinostat) In Myeloid Leukemia Cells

Nadja Blagitko-Dorfs, Ph.D., Tobias Bauer, M.Sc., Maren Prinz, Wolfram Brugger, MD, Gesine Bug, MD, PhD, Katharina Goetze, MD, Michael Heuser, MD, Sabine Kayser, MD, Hans Walter Lindemann, MD, Helmut R. Salih, MD, Björn W. Hackanson, MD, Michael Lübbert, MD

Blood (2013) 122 (21): 3763.

https://doi.org/10.1182/blood.V122.21.3763.3763

Published: 2013

Journal Articles

Expression Of Cancer-Testis Antigen In Multiple Myeloma

Jingna Ji, Jr, Shangqin Liu, Sr., PHD, Li He, Chaoping Xu, Jr., Guiying Hu, Yicheng Zhang, Zi Ma, Sr., Jianying Huang

Blood (2013) 122 (21): 5341.

https://doi.org/10.1182/blood.V122.21.5341.5341

Published: 2013

Journal Articles

Adoptive Transfer of Gene-Modified T-Cells Engineered to Express High-Affinity TCRs for Cancer-Testis Antigens (CTAs) NY-ESO-1 or Lage-1, in MM Patients Post Auto-SCT

Blood (2012) 120 (21): 472.

https://doi.org/10.1182/blood.V120.21.472.472

Published: 2012

Journal Articles

Inducible Expression of Cancer Testis Antigens in Myelodysplastic Syndrome (MDS) Patients Following Treatment with an Oral 5-Azacytidine

John Powers, B.S., Eva Sahakian, Ph.D, Jason A Dubovsky, Ph.D, Tyler Farnum, Emmanuel Berchmans, B.S., Douglas G McNeel, MD, Barry S. Skikne, MD, Kyle J MacBeth, Rami S. Komrokji, MD, Javier Pinilla-Ibarz, MD, PhD

Blood (2012) 120 (21): 3828.

https://doi.org/10.1182/blood.V120.21.3828.3828

Published: 2012

Journal Articles

Cancer/Testis Antigens MAGE-C1/CT7 and MAGE-C2/CT10 Are Expressed in 90% of Multiple Myeloma Samples and Can Be Explored in Combined Immunotherapy for This Malignancy

Fabricio de Carvalho, Veruska Lia, Fook Alves, Walter Moisés, Tobias Braga, M.D., Celso Vieira Xavier, Jr., Gisele Wally Braga Colleoni, MD

Blood (2012) 120 (21): 4974.

https://doi.org/10.1182/blood.V120.21.4974.4974

Published: 2012

Journal Articles

Tumor Antigens and T Cell Subpopulations: Is There Correlation Between These Two Possible Targets for Immunotherapy in Multiple Myeloma?

Walter Moises Tobias Braga, M.D., Bruna Raphaeli Silva, Fabricio de Carvalho, Veruska Lia Fook Alves, Gisele Wally Braga Colleoni, MD

Blood (2012) 120 (21): 4985.

https://doi.org/10.1182/blood.V120.21.4985.4985

Published: 2012

Journal Articles

Enhanced Immunological Responses Following K562/GM-CSF/CD40L Vaccine Plus Lenalidomide in High-Risk Myelodysplastic Syndrome

John Powers, B.S., Eric Padron, MD, Jason Dubovsky, Ph.D, Emmanuel Berchmans, B.S., Tyler Farnum, Fanqi Bai, MD, Eva Sahakian, Ph.D, Jamil Ahmed, Rami S. Komrokji, MD, Jeffrey E. Lancet, MD, Alan F. List, MD, Douglas G McNeel, MD, Sophie Dessureault, MD, Scott Antonia, MD, Eduardo M. Sotomayor, P.K. Epling-Burnette, PharmD, PhD, Javier Pinilla-Ibarz, MD, PhD

Blood (2011) 118 (21): 1725.

https://doi.org/10.1182/blood.V118.21.1725.1725

Published: 2011

NARROW

Ethical Issues and Barriers for Multi-National Paediatric Clinical Trials: The Challenging Experience of the DEEP Project

Mass Spectrometry-Based Immunopeptidome Analysis of Acute Myeloid Leukemia Cells Under Decitabine Treatment Delineates Induced Presentation of Cancer/Testis Antigens on HLA Class I Molecules

Somatic PRAME Deletions Are Associated with Decreased Immunogenicity, Apoptosis Resistance and Poor Outcomes in Diffuse Large B-Cell Lymphoma

TFDP3 and DDX53 are Highly Re-Expressed after One Cycle of Azacitidine in Myelodysplastic Syndrome Patients Achieving Complete Response: A Cancer Testis Antigen RNA-Seq Screening

Molecular profiling reveals immunogenic cues in anaplastic large cell lymphomas with DUSP22 rearrangements

Global and Targeted RNA-Sequencing Assessment of Cancer Testis Antigen Re-Expression Following Azacitidine in Myelodysplastic Syndromes

Transcriptomic and Network Signatures of Cryptic Fusion CBFA2T3-GLIS2 in Pediatric AML Reveals Clinical Considerations and Implications

Evaluation of Cancer Testis Antigens (CTAs) As Immuno-Therapeutic Targets in Pediatric AML

Induction of Cancer Testis Antigen Expression in Circulating Acute Myeloid Leukemia Blasts Following Hypomethylating Agent Monotherapy

Incidence of Pulmonary Embolism with Concomitant Deep Vein Thrombosis at an Urban Community Teaching Hospital

An Interphase Chromosome Profiling Assay to Determine the Need for CD 138 Enrichment in the Genetic Workup of Multiple Myeloma

Novel Evidence That Neuroblastoma and Rhabdomyosarcoma, Two Types of Small Round Blue Cell Tumors, Frequently Infiltrate Bone Marrow and Express Functional Erythropoietin Receptor (EpoR)—therapeutic Implications

The Cancer/Testis Antigens of SSX4, MAGE-A3, and CTAG2 Are Attractive Targets for Cancer Immunotherapy in Korean Patients with Multiple Myeloma

Synergistic Reactivation Of Cancer/Testis Antigens By Combination Treatment With Decitabine and Histone Deacetylase Inhibitors (Valproate, Panobinostat) In Myeloid Leukemia Cells

Expression Of Cancer-Testis Antigen In Multiple Myeloma

Adoptive Transfer of Gene-Modified T-Cells Engineered to Express High-Affinity TCRs for Cancer-Testis Antigens (CTAs) NY-ESO-1 or Lage-1, in MM Patients Post Auto-SCT

Inducible Expression of Cancer Testis Antigens in Myelodysplastic Syndrome (MDS) Patients Following Treatment with an Oral 5-Azacytidine

Cancer/Testis Antigens MAGE-C1/CT7 and MAGE-C2/CT10 Are Expressed in 90% of Multiple Myeloma Samples and Can Be Explored in Combined Immunotherapy for This Malignancy

Tumor Antigens and T Cell Subpopulations: Is There Correlation Between These Two Possible Targets for Immunotherapy in Multiple Myeloma?

Enhanced Immunological Responses Following K562/GM-CSF/CD40L Vaccine Plus Lenalidomide in High-Risk Myelodysplastic Syndrome

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only